Kewaunee Scientific Co. (NASDAQ:KEQU) Short Interest Up 23.8% in October

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 40,100 shares, a growth of 23.8% from the October 15th total of 32,400 shares. Approximately 1.9% of the company's shares are short sold. Based on an average daily volume of 22,500 shares, the short-interest ratio is currently 1.8 days.

Kewaunee Scientific Stock Down 0.5 %

NASDAQ:KEQU traded down $0.19 during trading hours on Friday, reaching $37.90. 6,164 shares of the company traded hands, compared to its average volume of 13,719. Kewaunee Scientific has a 1 year low of $16.51 and a 1 year high of $55.62. The stock has a market capitalization of $108.77 million, a P/E ratio of 6.08 and a beta of 0.73. The business's 50-day moving average price is $34.92 and its two-hundred day moving average price is $41.56. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its earnings results on Wednesday, September 11th. The technology company reported $0.93 EPS for the quarter. Kewaunee Scientific had a return on equity of 25.87% and a net margin of 9.13%. The business had revenue of $48.39 million during the quarter.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its holdings in Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after acquiring an additional 1,941 shares during the period. Barclays PLC bought a new stake in Kewaunee Scientific during the third quarter valued at approximately $121,000. State Street Corp bought a new stake in Kewaunee Scientific during the third quarter valued at approximately $266,000. De Lisle Partners LLP raised its position in Kewaunee Scientific by 36.6% in the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company's stock worth $1,446,000 after acquiring an additional 11,511 shares during the period. Finally, Ritholtz Wealth Management boosted its stake in shares of Kewaunee Scientific by 24.6% during the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company's stock worth $363,000 after acquiring an additional 2,156 shares during the last quarter. Institutional investors own 32.69% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.